These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21596928)

  • 1. Regulation of human vascular protease-activated receptor-3 through mRNA stabilization and the transcription factor nuclear factor of activated T cells (NFAT).
    Rosenkranz AC; Rauch BH; Doller A; Eberhardt W; Böhm A; Bretschneider E; Schrör K
    Mol Pharmacol; 2011 Aug; 80(2):337-44. PubMed ID: 21596928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of protease-activated receptor-1 by vasodilatory prostaglandins via NFAT.
    Rosenkranz AC; Rauch BH; Freidel K; Schrör K
    Cardiovasc Res; 2009 Sep; 83(4):778-84. PubMed ID: 19460777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional inhibition of protease-activated receptor-1 expression by prostacyclin in human vascular smooth muscle cells.
    Pape R; Rauch BH; Rosenkranz AC; Kaber G; Schrör K
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):534-40. PubMed ID: 18162607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High glucose enhances thrombin responses via protease-activated receptor-4 in human vascular smooth muscle cells.
    Dangwal S; Rauch BH; Gensch T; Dai L; Bretschneider E; Vogelaar CF; Schrör K; Rosenkranz AC
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):624-33. PubMed ID: 21164077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin receptors in vascular smooth muscle cells - function and regulation by vasodilatory prostaglandins.
    Schrör K; Bretschneider E; Fischer K; Fischer JW; Pape R; Rauch BH; Rosenkranz AC; Weber AA
    Thromb Haemost; 2010 May; 103(5):884-90. PubMed ID: 20143010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic functions of tetradecanoyl phorbol acetate-inducible-sequence 11b and HuR in the hormonal regulation of vascular endothelial growth factor messenger ribonucleic acid stability by adrenocorticotropin.
    Cherradi N; Lejczak C; Desroches-Castan A; Feige JJ
    Mol Endocrinol; 2006 Apr; 20(4):916-30. PubMed ID: 16306087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells.
    Bretschneider E; Kaufmann R; Braun M; Nowak G; Glusa E; Schrör K
    Br J Pharmacol; 2001 Apr; 132(7):1441-6. PubMed ID: 11264237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C alpha-dependent phosphorylation of the mRNA-stabilizing factor HuR: implications for posttranscriptional regulation of cyclooxygenase-2.
    Doller A; Huwiler A; Müller R; Radeke HH; Pfeilschifter J; Eberhardt W
    Mol Biol Cell; 2007 Jun; 18(6):2137-48. PubMed ID: 17392515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of human antigen R, an RNA-binding protein, in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin: a novel mechanism involved in vascular inflammation.
    Lin FY; Chen YH; Lin YW; Tsai JS; Chen JW; Wang HJ; Chen YL; Li CY; Lin SJ
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2622-9. PubMed ID: 16990552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for functionally active protease-activated receptor-3 (PAR-3) in human vascular smooth muscle cells.
    Bretschneider E; Spanbroek R; Lötzer K; Habenicht AJ; Schrör K
    Thromb Haemost; 2003 Oct; 90(4):704-9. PubMed ID: 14515192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox regulation of human protease-activated receptor-2 by activated factor X.
    Jobi K; Rauch BH; Dangwal S; Freidel K; Doller A; Eberhardt W; Fischer JW; Schrör K; Rosenkranz AC
    Free Radic Biol Med; 2011 Nov; 51(9):1758-64. PubMed ID: 21871560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thrombin, the thrombin receptor activation peptide, and other mitogens on vascular smooth muscle cell urokinase receptor mRNA levels.
    Reuning U; Little SP; Dixon EP; Bang NU
    Blood; 1994 Dec; 84(11):3700-8. PubMed ID: 7949125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human-antigen R (HuR) expression in hypertension: downregulation of the mRNA stabilizing protein HuR in genetic hypertension.
    Klöss S; Rodenbach D; Bordel R; Mülsch A
    Hypertension; 2005 Jun; 45(6):1200-6. PubMed ID: 15883232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of soluble guanylyl cyclase expression by cyclic AMP is mediated by mRNA-stabilizing protein HuR.
    Klöss S; Srivastava R; Mülsch A
    Mol Pharmacol; 2004 Jun; 65(6):1440-51. PubMed ID: 15155837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HuR and myogenesis: being in the right place at the right time.
    von Roretz C; Beauchamp P; Di Marco S; Gallouzi IE
    Biochim Biophys Acta; 2011 Sep; 1813(9):1663-7. PubMed ID: 21315776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate induces thrombin receptor PAR-4 expression to enhance cell migration and COX-2 formation in human monocytes.
    Mahajan-Thakur S; Sostmann BD; Fender AC; Behrendt D; Felix SB; Schrör K; Rauch BH
    J Leukoc Biol; 2014 Oct; 96(4):611-8. PubMed ID: 24990321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of eotaxin gene expression by TNF-alpha and IL-4 through mRNA stabilization: involvement of the RNA-binding protein HuR.
    Atasoy U; Curry SL; López de Silanes I; Shyu AB; Casolaro V; Gorospe M; Stellato C
    J Immunol; 2003 Oct; 171(8):4369-78. PubMed ID: 14530362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide destabilizes cyclooxygenase-2 mRNA by inhibiting p38 mitogen-activated protein kinase and cytoplasmic shuttling of HuR.
    Jin SH; Kim TI; Yang KM; Kim WH
    Eur J Pharmacol; 2007 Mar; 558(1-3):14-20. PubMed ID: 17208222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. v-Src oncogene product increases sphingosine kinase 1 expression through mRNA stabilization: alteration of AU-rich element-binding proteins.
    Sobue S; Murakami M; Banno Y; Ito H; Kimura A; Gao S; Furuhata A; Takagi A; Kojima T; Suzuki M; Nozawa Y; Murate T
    Oncogene; 2008 Oct; 27(46):6023-33. PubMed ID: 18574469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Il-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability.
    Cuneo AA; Herrick D; Autieri MV
    J Mol Cell Cardiol; 2010 Oct; 49(4):647-54. PubMed ID: 20451530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.